Countdown to close
$
16.63
Change
+0.30 +1.81%
Volume
Volume 41.17m
Sep 8, 2010, 3:35 p.m.
Real time quotes
Previous close
$ 16.33
$ 16.63
Change
+0.30 +1.81%
Day low
Day high
$16.30
$16.65
52 week low
52 week high
$14.00
$20.36
Market cap
$133.68B
Average volume
51.15M
P/E ratio
11.51
EPS
1.45
Dividend
0.18
Div yield
4.41%
Ex dividend date
8/4/10
MarketWatch News on PFE
-
f63a3807-384a-4313-8178-5c0fec874e1a:1559
Friday's biggest gaining and declining stocks
- MarketWatch
-
f63a3807-384a-4313-8178-5c0fec874e1a:1549
Celldex plunges; drug stock indexes climb
- Val Brickates Kennedy
-
f63a3807-384a-4313-8178-5c0fec874e1a:1536
A roster of dividend-paying stocks to consider
- Russ Britt
-
f63a3807-384a-4313-8178-5c0fec874e1a:1533
Investor Einhorn doubles down on Microsoft, Xerox
- Matt Andrejczak
-
f63a3807-384a-4313-8178-5c0fec874e1a:1532
Investor David Einhorn doubles down on Microsoft
- Matt Andrejczak
-
f63a3807-384a-4313-8178-5c0fec874e1a:1531
Investor Einhorn ups stakes in Microsoft, Pfizer
- Matt Andrejczak
-
f63a3807-384a-4313-8178-5c0fec874e1a:1530
Depomed, Dendreon lead drug stocks higher
- Val Brickates Kennedy
-
f63a3807-384a-4313-8178-5c0fec874e1a:1525
U.S. stocks fall after lackluster earnings, data
- Donna Kardos Yesalavich
-
f63a3807-384a-4313-8178-5c0fec874e1a:1521
Tuesday's biggest gaining and declining stocks
- MarketWatch
-
f63a3807-384a-4313-8178-5c0fec874e1a:1517
Wyeth sales stoke Pfizer's earnings
- Val Brickates Kennedy
-
f63a3807-384a-4313-8178-5c0fec874e1a:1515
Pfizer leads drug stocks north; Akorn slides
- Val Brickates Kennedy
-
f63a3807-384a-4313-8178-5c0fec874e1a:1513
Stalling, for the moment, on economic tug-of-war- Andrew O'Day
-
f63a3807-384a-4313-8178-5c0fec874e1a:1490
Pfizer leads large-caps in early trading
- Val Brickates Kennedy
-
f63a3807-384a-4313-8178-5c0fec874e1a:1486
Pfizer shares gain 3.7% in early trade
- Laura Mandaro
-
f63a3807-384a-4313-8178-5c0fec874e1a:1483
Futures drop after Dow Chemical, P&G earnings
- Polya Lesova
- Loading more headlines...
Where does this data come from?
Hulbert Interactive »
For more than 25 years, the Hulbert database has tracked the performance and recommendations of over 180 investment newsletters.
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Community (MarketWatch) »
Sentiment for this symbol comes from users like you, the MarketWatch community, on active picks. Make picks below to participate.
Sentiment on PFE
Where will PFE close from its current price?
Other News on PFE
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4154
Similar Companies Don't Always Have Similar Stocks
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4147
- 247WallSt.com
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4146
Big Pharma Headed for More Deals, Less New Drug Applications
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4145
- CNW Group
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4144
Investment Opportunities in AML Frontline Therapies
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4143
CellDex Therapeutics Gets Hammered After Divorce With Pfizer, Time to Buy?
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4141
Arena's Lorcaserin: Weighed Down by Qnexa and Meridia
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4135
A Look at Immunogen Beyond the T-DM1 Setback
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4134
Pfizer Could Reface up to 1,000 Lawsuits on HRT Complications
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4132
4 Dividend Aristocrats with Attractive Yields for Value Investors
- Seeking Alpha
-
9dd8789f-98e9-4856-a8f6-ecc4719093cb:4131
Pfizer: You'd Have to Be Sick to Touch This Drug Stock
- Seeking Alpha
- Loading more headlines...
Press Releases on PFE
-
150e4215-7676-4254-b655-c9cf362cffee:429
Pfizer Animal Health, AKC Canine Health Foundation Form Exclusive Research Alliance
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:428
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:427
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:426
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:425
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:423
MS LifeLines(R) Reaches Milestone of Servicing One Million In-Bound Calls
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:422
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
- BusinessWire
-
150e4215-7676-4254-b655-c9cf362cffee:421
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:420
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:419
Marina Biotech, Inc. Announces Second Quarter 2010 Financial Results
- Marketwire
-
150e4215-7676-4254-b655-c9cf362cffee:418
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:417
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:416
Progenics Pharmaceuticals Announces Second Quarter 2010 Financial Results
- BusinessWire
-
150e4215-7676-4254-b655-c9cf362cffee:415
- GlobeNewswire
-
150e4215-7676-4254-b655-c9cf362cffee:414
- PR Newswire
-
150e4215-7676-4254-b655-c9cf362cffee:413
Depomed Receives Confirmation from Pfizer That No Infringement Suit to be Filed on DM-1796 NDA
- GlobeNewswire
-
150e4215-7676-4254-b655-c9cf362cffee:411
- Marketwire
-
150e4215-7676-4254-b655-c9cf362cffee:410
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
- PR Newswire
- Loading more headlines...








